Virulence attenuation of Candida albicans genetic variants isolated from a patient with a recurrent bloodstream infection.
The incidence of Candida albicans infections and the relapse episodes after antifungal treatment have increased in recent decades. Recurrences are mainly due to the persistence of the original infecting strain that may present genetic and genomic rearrangements during interaction with the host, reflecting strain adaptation. In this study, four isolates recovered from a patient during recurrent candidemia episodes were genotyped by microsatellite length polymorphism (MLP) and by multilocus sequence typing (MLST) and found to be genetic variants of the same strain. Using experimental mouse infections, a progressive reduction in the virulence of the four isolates was observed, with the first two isolates more virulent than the third and fourth. Additionally, in the mouse model, the first isolate resisted host control more efficiently, resulting in higher kidney fungal burdens and necrosis as compared to the third isolate. The resolution of inflammation was delayed in mice challenged with the first isolate and the message for IFN-gamma and TNF-alpha in the spleen was lower within the first few hours post-infection. Original and recurrent isolates also displayed different phenotypes regarding activity of secreted enzymes and response to stress agents. Overall, the comparative analysis indicated that the virulence decrease of these isolates was related to a lower ability to resist to the host anticandida effector mechanisms. We showed for the first time that C. albicans genetic variants of the same strain, sequentially isolated from an immunocompromised patient, underwent adaptations in the human host that resulted in virulence attenuation when tested in mice.
Sampaio
Paula
P
Centre of Molecular and Environmental Biology, Department of Biology, University of Minho, Braga, Portugal.
Santos
Marlene
M
Correia
Alexandra
A
Amaral
Fábio E
FE
Chavéz-Galarza
Julio
J
Costa-de-Oliveira
Sofia
S
Castro
António G
AG
Pedrosa
Jorge
J
Pais
Célia
C
D000818:Animals; D002176:Candida albicans / Q000235:genetics* / Q000302:isolation & purification / Q000472:pathogenicity*; D002177:Candidiasis / Q000382:microbiology*; D016469:Fungemia / Q000382:microbiology*; D014644:Genetic Variation; D006801:Humans; D007249:Inflammation / Q000382:microbiology; D007371:Interferon-gamma / Q000032:analysis; D051379:Mice; D012008:Recurrence; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D014774:Virulence / Q000235:genetics
D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma
Blood. 2000 Jun 15;95(12):3725-33
10845903
Microbiol Mol Biol Rev. 2007 Jun;71(2):348-76
17554048
Infect Immun. 2005 Oct;73(10):6299-310
16177301
J Immunol. 1986 Nov 1;137(9):2980-4
3093587
J Clin Microbiol. 2004 Oct;42(10):4726-34
15472333
Oral Microbiol Immunol. 2002 Oct;17(5):311-4
12354213
Infect Immun. 1999 Aug;67(8):4280-4
10417206
Microbiology (Reading). 2004 Sep;150(Pt 9):2807-2813
15347740
J Leukoc Biol. 2007 Oct;82(4):915-25
17652450
FEMS Yeast Res. 2008 Dec;8(8):1334-8
18795958
J Clin Microbiol. 2005 Aug;43(8):3869-76
16081924
J Infect Dis. 2004 Aug 1;190(3):624-31
15243941
Diagn Microbiol Infect Dis. 1990 Sep-Oct;13(5):383-6
2126496
J Comp Physiol B. 2004 Jul;174(5):421-7
15148621
J Leukoc Biol. 2000 Aug;68(2):175-9
10947060
Microbiology (Reading). 2003 Feb;149(Pt 2):333-339
12624195
J Immunol Methods. 1996 Oct 16;197(1-2):139-50
8890901
Mol Microbiol. 2005 Apr;56(2):397-415
15813733
Mycoses. 2005 May;48(3):151-61
15842329
J Clin Microbiol. 1995 Jun;33(6):1501-9
7650175
Front Biosci (Landmark Ed). 2009 Jan 01;14:4363-75
19273355
Curr Opin Microbiol. 1999 Aug;2(4):363-7
10458979
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):373-80
9833746
Eukaryot Cell. 2004 Oct;3(5):1076-87
15470236
Infect Dis Clin North Am. 2006 Sep;20(3):485-506
16984866
J Immunol. 1999 Aug 1;163(3):1498-505
10415052
Med Mycol. 2006 Mar;44(2):149-57
16519018
J Med Microbiol. 2006 Jul;55(Pt 7):809-818
16772406
Antimicrob Agents Chemother. 1985 Apr;27(4):625-31
3890731
J Clin Microbiol. 2003 Nov;41(11):5265-6
14605179
Microbiology (Reading). 1998 Oct;144 ( Pt 10):2731-2737
9802014
Curr Opin Microbiol. 2003 Aug;6(4):338-43
12941401
Cell Microbiol. 2007 Feb;9(2):492-501
16987332
J Clin Microbiol. 2006 Oct;44(10):3647-58
17021093
Curr Pharm Des. 2006;12(32):4195-201
17100622
J Immunol. 2005 Apr 1;174(7):4345-55
15778399
Microbes Infect. 2006 Mar;8(3):612-20
16503182
Med Mycol. 2007 Jun;45(4):321-46
17510856
J Infect Dis. 1993 Aug;168(2):436-43
8335982
Mol Biol Evol. 2007 Aug;24(8):1596-9
17488738
Genetics. 2009 Jul;182(3):799-811
19414562
Mol Cells. 2005 Oct 31;20(2):271-9
16267403
Sabouraudia. 1984;22(3):201-7
6379916
Eur J Immunol. 2007 Jan;37(1):224-34
17154261
J Exp Med. 2009 Feb 16;206(2):269-73
19204107
Eukaryot Cell. 2009 Mar;8(3):373-87
19151328
Exp Parasitol. 2007 Jan;115(1):68-75
16889774
Int Immunol. 1998 Jan;10(1):37-48
9488154
Fungal Genet Biol. 2009 Feb;46(2):159-68
19059493
J Immunol. 1998 Jan 1;160(1):284-92
9551982
Oral Microbiol Immunol. 2004 Oct;19(5):293-6
15327640
Curr Drug Targets. 2006 Apr;7(4):483-94
16611036
Infect Immun. 1998 Apr;66(4):1708-17
9529101
Eukaryot Cell. 2002 Oct;1(5):657-62
12455685
Infect Immun. 1999 Dec;67(12):6637-42
10569785
Nat Rev Immunol. 2004 Jan;4(1):1-23
14661066
J Infect Dis. 1995 May;171(5):1279-88
7751704
BMC Microbiol. 2008 Oct 24;8:187
18950481
Eur J Appl Physiol. 2005 Mar;93(5-6):714-8
15517337
J Clin Microbiol. 1997 Jul;35(7):1777-80
9196192
Curr Opin Microbiol. 2002 Aug;5(4):359-65
12160853
Eur J Immunol. 1981 Oct;11(10):805-15
7308288
J Clin Microbiol. 2004 Sep;42(9):4025-31
15364985
Evolution. 2009 Apr;63(4):950-8
19210533